Market Overview
Global Modular Laboratory Automation Market size was valued at USD 5.21 Billion in 2023 and is poised to grow from USD 5.95 Billion in 2024 to USD 17.26 Billion by 2032, growing at a CAGR of 14.2% in the forecast period (2024-2032).
Modular Laboratory Automation is a versatile, expandable, and unified method of laboratory workflow, aimed at enhancing efficiency, accuracy, and throughput in multiple scientific and medical applications. As more precision, reproducibility, and quicker results become the need in lab processes, modular automation systems have become increasingly popular. These systems are composed of modular units that may be tailored to fit the individual requirements of a laboratory, ensuring streamlined operation with minimal manual intervention. The modularity of the system ensures that additional or removal of elements can be easily done, making the system flexible to adjustments in research requirements or expansion in laboratories.
The complexification of laboratory procedures, particularly in areas such as genomics, drug discovery, and clinical diagnostics, has fuelled the need for automation. Conventional laboratory methods tend to be time-consuming and subject to human error, which translates into inefficiency and compromised outcomes. Through the automation of time-consuming and repetitive steps, modular laboratory automation systems improve experiment accuracy and reproducibility while allowing laboratories to process greater volumes of samples within shorter time intervals. Automation also facilitates the minimization of contamination risk, enhances safety, and assures compliance with regulatory requirements.
Besides optimizing laboratory efficiency, modular automation systems provide smooth integration with different laboratory instruments and software systems, making them a single platform for data collection and analysis. Modular automation systems can be designed to meet many laboratory functions, such as liquid handling, sample preparation, high-throughput screening, and data collection. For example, automated liquid handling systems have the ability to handle several samples at once, greatly minimizing the time needed for operations such as reagent mixing, sample dilution, and assay preparation. Similarly, robotic arms can aid in the accurate and precise manipulation of laboratory supplies, while storage and retrieval systems keep samples and data organized and readily available.
Another key benefit of modular lab automation is its support for high-level research and development operations. Within industries like pharmaceuticals and biotechnology, time and precision being paramount, automation speeds the invention of novel drugs, diagnostics, and technology. Additionally, tying automation together with artificial intelligence and machine learning methods is bringing with it new paradigms of data interpretation and decision-making to enhance overall quality of results of research.
Market Drivers
Increasing Demand for High-Throughput and Accurate Results in Laboratories
- The need for high-throughput and precise outcomes within laboratories is being driven by growing demands for fast and reliable data applied in scientific research, clinical diagnostics, and drug development. As the volume of data and samples that laboratories must process continues to grow, standard manual methods cannot be sufficient in meeting the rate and precision required. It is high-throughput ability that enables labs to conduct large experiments, operate multiple samples, and analyze high-level data in less time. It is automation that can provide this requirement because samples can be processed in parallel, requiring much less time to perform tests and experiments.
- Besides, automation is more precise by reducing human errors, providing consistency in repetitive operations, and optimizing reproducibility of results. With the growing demand for quicker turnaround times in drug discovery, clinical trials, and diagnostic testing, laboratories are now more reliant on automation to deliver high throughput and high precision, and it has become a part of contemporary research and diagnostic procedures. This is also followed by the growth of personalized medicine, where accurate and precise information has a crucial role in individualizing treatment for patients on a customized level, thereby increasing the demand for laboratory automation globally.
Growing Need to Reduce Human Error and Improve Reproducibility in Experiments
- One of the main reasons for employing modular laboratory automation systems is the increasing necessity to minimize human error and allow reproducibility in experiments. A lot of processes within a normal laboratory follow manual methods, which might be prone to errors, consist of variability, and get tired when repeating steps. Even minor measurement errors, sample handling, or data acquisition can lead to enormous discrepancies in outcomes, compromising the reliability and validity of scientific research. Such errors could make research obsolete, slow progress, and entail expensive delays. Automation avoids all this by automating laboratory procedures and allowing repeatable accurate movements, e.g., accurate treatment of liquids, sample preparation, and data registration. In automation, the origin of variability inherent in human influence is largely removed, leading to more reproducible and uniform results. This enhancement of reproducibility is very vital in applications involving high risks, like in clinical diagnosis and drug research, where accuracy in findings directly influences treatment outcome and patients' welfare. Limiting human error and reproducibility to an even higher degree, modular lab automation not only enhances the collective quality of the experiment but also accelerates the development process of scientific discovery and progress.
Market Opportunities
Expanding Research and Development Activities in Biotechnology and Pharmaceuticals
- Spurt in R&D activities in pharmaceuticals and biotechnology is propelling strong demand for modular laboratory automation systems. With the biotech and pharma companies repeatedly expanding the frontiers of science, there is greater demand for sophisticated technologies to hasten drug discovery, augment testing, and improve clinical trial productivity. Automation is the foundation of this growth through the ability of researchers to manage large-scale experiments and manipulate complex data at a faster and more precise level. In biotechnology, for example, automation provides high-throughput screening, genomics research, and proteomics analysis, significantly lowering the time and effort required in such operations.
- In pharmaceuticals, automation enables new drug development and testing, making experiments reproducible, results reliable, and regulatory compliance ensured. Demand for targeted medicine, where cures are tailored based on a person's genetic profile, is another where the need for automation is stressed due to its ability to process massive amounts of data and handle samples with precision. The ability for more experiments to be performed in less time with higher accuracy is driving innovation in drug discovery and accelerating the pace at which new treatments reach the market. As R&D activities in these sectors increase, modular laboratory automation systems are emerging as a key asset to remain competitive and deliver new biotechnological and pharmaceutical products successfully.
Market Restraining Factors
Complexity in Integrating Modular Systems with Existing Laboratory Infrastructure
- Incorporation of modular systems into existing laboratory facilities is a major challenge in the majority of laboratories, especially those with established workflows and aging equipment. Modular automation systems, being flexible and expandable, are usually well-planned and tailored to integrate smoothly with installed equipment, software, and data handling systems. The integration process will include potential compatibility issues between fresh automation technologies and current equipment, which may be technically not suited to communicate with contemporary automated solutions.
- Lab facilities now will need expensive rebuilds or retrofitting since they lack the digital interfaces and standardization required to accommodate new modules. To enable lab personnel's proper use and debugging of new systems, integration also necessitates extensive training. Moreover, disruption of current operations or research translates into delays, downtime, and short-term inefficiency. Therefore, integration with the existing infrastructure can be an issue of complexity, particularly for small laboratories or where technology capability and finance are limited. However, by proper planning, phased implementation, and coordination with system providers, integration issues can be addressed, and modular automation as a sound investment in the long term.
Segmentation Analysis
The market scope is segmented because of by Product Type, by Application, by Component, by End User.
Based on the Product Type of the market is segmented into Automated Liquid Handling Systems, Automated Storage & Retrieval Systems, Automated Plate Handling Systems, Robotic Arms, Others.
Among the different product type segments of the modular laboratory automation market, Automated Liquid Handling Systems have been the market leaders. This is largely because they play a pivotal role in improving efficiency, accuracy, and throughput in laboratories in various industries such as pharmaceuticals, biotechnology, and clinical diagnostics.
Automated liquid handling instruments are used to control the precise movement, blending, and transferring of liquids, including reagents, samples, and solvents. Automated liquid handling systems play a critical role in high-throughput settings where sample preparation, dilution, and assay development must be performed with high reproducibility and accuracy. Liquid handling is perhaps the most human-error-prone and labour-intensive step in laboratory processes, rendering automation crucial to reducing human error and enhancing reproducibility.
Based on the Application of the market is segmented into Clinical Diagnostics, Drug Discovery, Genomics, Proteomics, Chemical Analysis, Others.
Clinical diagnostics have been the prominent use of the Modular Laboratory Automation Market. It is so because of increased needs for speedy, precise, and sound diagnostics results in hospitals and clinics. Clinical diagnostics consist of high-throughput tests including disease screening, analysis of patients' samples, and routine tests which all are hugely benefited with automation. Automated clinical diagnostics reduce man-made errors, accelerate sample processing, and produce reproducible and consistent results, which is of very critical nature in patient care. The demand for quick turnaround times, particularly in infectious diseases testing, blood testing, and molecular diagnostics, makes automated systems very critical to clinical laboratories.
Growing incidences of chronic diseases, population aging, and growing prevalence of diseases such as cancer, diabetes, and cardiovascular diseases have enhanced the demand for diagnostic accuracy. Automation addresses this demand by enabling laboratories to manage increased volumes of tests with maximum efficiency and precision, which is crucial in terms of addressing contemporary healthcare demands. Also, the rise in trend of personalized medicine where diagnostics is tailored to suit an individual's patient profile has supported the integration of modular automation systems in clinical diagnostics.
By region, Insights into the markets in North America, Europe, Asia-Pacific, Latin America and MEA are provided by the study. North America has dominated the Modular Laboratory Automation Market, driven by its advanced healthcare infrastructure, high investment in research and development (R&D), and strong presence of key pharmaceutical and biotechnology companies. North America is adequately equipped with a large number of well-known healthcare facilities, research centres, and diagnostic labs that are increasingly adopting automation to improve efficiency, accuracy, and scalability of laboratory operations. The United States, in particular, is at the forefront of clinical diagnostics, drug development, and genomic research, which all rely on automation systems. The strong interest in personalized medicine within the area and the escalating requirement for speed and accuracy diagnostic outcomes have imposed a need on modular laboratory automation systems to become leading tools within healthcare settings. Besides, North America has good funding for technological innovation and therefore represents an ideal market for automation vendors. The Asia-Pacific market, on the other hand, would be the quickest-growing market for modular laboratory automation. This is due to the massive growth in the healthcare and life sciences industries, combined with mounting investment in healthcare infrastructure and R&D in nations such as China, India, and Japan.
The area is also experiencing a rise in demand for quality healthcare centres, rising applications of lab automation technologies, and government efforts towards enhancing health care and diagnosis. Moreover, the Asia-Pacific region is becoming a centre for drug production and clinical trials globally, again creating demands for lab automation.
List of Companies Profiled
- Thermo Fisher Scientific
- Danaher Corporation
- Hudson Robotics Inc.
- Becton Dickinson
- Synchron Lab Automation
- Siemens Healthcare
- Perkinelmer Inc.
- Honeywell International Inc.
- Tecan Group Ltd
- Agilent Technologies
Key Industry Developments
In July 2024, Kronos Worldwide, Inc. ("Kronos") has purchased the remaining 50% joint venture interest in Louisiana Pigment Company, L.P. ("LPC") from Venator Investments, Ltd. Kronos, through a wholly-owned subsidiary, previously owned a 50% interest in LPC. Through this acquisition, LPC is now an indirect, wholly-owned subsidiary of Kronos. The purchase consideration was an upfront cash payment of $185 million (subject to adjustment for working capital) and a possible earn-out payment of up to $15 million dependent upon Kronos' consolidated net income before interest, taxes, depreciation, and amortization (EBITDA) during the two-year period 2025 and 2026.
In December 2023, Evonik has finalized its full acquisition of the former joint venture, Thai Peroxide Company Limited (TPL), located in Saraburi, Thailand. The acquisition, which was completed on December 15, allows the worldwide peroxide manufacturer to expand its portfolio of specialty-grade hydrogen peroxide and peracetic acid in the fast-growing Asia Pacific region. The acquisition is part of Evonik's Active Oxygens business line's strategic emphasis on specialties for new applications.
Report Coverage
The report will cover the qualitative and quantitative data on the Global Modular Laboratory Automation Market. The qualitative data includes latest trends, market players analysis, market drivers, market opportunity, and many others. Also, the report quantitative data includes market size for every region, country, and segments according to your requirements. We can also provide customize report in every industry vertical.
Report Scope and Segmentations
Study Period | 2024-32 |
Base Year | 2023 |
Estimated Forecast Year | 2024-32 |
Growth Rate | CAGR of 14.2% from 2024 to 2032 |
Segmentation | By Product Type, By Application, By Component, By End User, By Region |
Unit | USD Billion |
By Product Type | - Automated Liquid Handling Systems
- Automated Storage & Retrieval Systems
- Automated Plate Handling Systems
- Robotic Arms
- Others
|
By Application | - Clinical Diagnostics
- Drug Discovery
- Genomics
- Proteomics
- Chemical Analysis
- Others
|
By Component | |
By End User | - Pharmaceutical Companies
- Biotechnology Companies
- Research Institutes
- Academic Institutions
- Diagnostic Laboratories
|
By Region | - North America (U.S., Canada, Mexico)
- Europe (Germany, France, UK, Italy, Spain, Russia, Rest of Europe)
- Asia-Pacific (China, India, Japan, ASEAN, Rest of Asia-Pacific)
- Latin America (Brazil, Mexico, Rest of Latin America)
- MEA (Saudi Arabia, South Africa, UAE, Rest Of MEA)
|
Global Modular Laboratory Automation Market Regional Analysis
North America accounted for the highest xx% market share in terms of revenue in the Modular Laboratory Automation market and is expected to expand at a CAGR of xx% during the forecast period. This growth can be attributed to the growing adoption of Modular Laboratory Automation. The market in APAC is expected to witness significant growth and is expected to register a CAGR of xx% over upcoming years, because of the presence of key Modular Laboratory Automation companies in economies such as Japan and China.
The objective of the report is to present comprehensive analysis of Global Modular Laboratory Automation Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language.
Modular Laboratory Automation Market Report is also available for below Regions and Country Please Ask for that
North America
Europe
- Switzerland
- Belgium
- Germany
- France
- U.K
- Italy
- Spain
- Sweden
- Netherland
- Turkey
- Rest of Europe
Asia-Pacific
- India
- Australia
- Philippines
- Singapore
- South Korea
- Japan
- China
- Malaysia
- Thailand
- Indonesia
- Rest Of APAC
Latin America
- Mexico
- Argentina
- Peru
- Colombia
- Brazil
- Rest of South America
Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- South Africa
- Rest Of MEA
Points Covered in the Report
- The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
- The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analysed 5 years data history and forecast.
- The growth factors of the market are discussed in detail wherein the different end users of the market are explained in detail.
- Data and information by market player, by region, by type, by application and etc., and custom research can be added according to specific requirements.
- The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.
Key Questions
- How much the global Modular Laboratory Automation Market valued?
- Which region has the largest share in 2024 for the global Modular Laboratory Automation Market?
- What are the driving factors for the market?
- Which is the leading segment in the global market?
- What are the major players in the market?
Research Scope of Modular Laboratory Automation Market
- Historic year: 2019-2022
- Base year: 2023
- Forecast: 2024 to 2032
- Representation of Market revenue in USD Million
Modular Laboratory Automation Market Trends: Market key trends which include Increased Competition and Continuous Innovations Trends: